Ausgabe 3/2004
Inhalt (13 Artikel)
Estimating rural households’ willingness to pay for health insurance
Ali Asgary, Ken Willis, Ali Akbar Taghvaei, Mojtaba Rafeian
Measuring and comparing the (in)efficiency of German and Swiss hospitals
Lukas Steinmann, Gunnar Dittrich, Alexander Karmann, Peter Zweifel
Costs and consequences of botulinum toxin type A use
Francis J. Ruiz, Julian F. Guest, Almut Lehmann, Alison M. Davie, Karen Güttler, Olaf Schlüter, Götz Dreiss
The cost structure of lung tuberculosis in Germany
Roland Diel, Bernhard Rappenhöner, Tom Schaberg
Financing of health care services in Hungary
Imre Boncz, Júlia Nagy, Andor Sebestyén, László Kőrösi
Health care provider payment mechanisms in the new EU members of Central Europe and the Baltic states
Agota Szende, Zsolt Mogyorosy
Reimbursement of glitazones in treatment of type 2 diabetes patients in Denmark in the context of a voluntary system for submitting pharmacoeconomic studies
Hindrik Vondeling, Peter Bindslev Iversen
Costs of treatment of colorectal cancer in different settings in Germany
Klaus Hieke, Ulrich R. Kleeberg, Martina Stauch, Axel Grothey
Out-patient drug policy by clinical assessment rather than financial constraints?
Marja H. Pronk, Gouke J. Bonsel
A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain
Juan Antonio Gómez-Gerique, Roman Casciano, Lee Stern, Javier Rejas